140 related articles for article (PubMed ID: 37821375)
1. [A case of rectal cancer with immune thrombocytopenic purpura that achieved a complete response to continued chemotherapy with eltrombopag].
Tanaka Y; Kuroda H; Honma K; Wakaki K
Nihon Shokakibyo Gakkai Zasshi; 2023; 120(10):852-857. PubMed ID: 37821375
[TBL] [Abstract][Full Text] [Related]
2. Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article.
Gao Y; Gong M; Zhang C; Kong X; Ma Y
Medicine (Baltimore); 2017 Oct; 96(43):e8337. PubMed ID: 29069007
[TBL] [Abstract][Full Text] [Related]
3. Metastatic rectal neuroendocrine carcinoma presenting with treatment-refractory immune thrombocytopenia: A case report and literature review.
Bancheno WM; Adidam SR; Melaku MA
Medicine (Baltimore); 2022 Jul; 101(29):e29616. PubMed ID: 35866784
[TBL] [Abstract][Full Text] [Related]
4. [Severe thrombocytopenia refractory to platelet transfusions, secondary to abciximab readministration, in a patient previously diagnosed with idiopathic thrombocytopenic purpura. A possible etiopathogenic link].
Méndez TC; Díaz O; Enríquez L; Baz JA; Fernández F; Goicolea J
Rev Esp Cardiol; 2004 Aug; 57(8):789-91. PubMed ID: 15282070
[TBL] [Abstract][Full Text] [Related]
5. Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia.
González-López TJ; Pascual C; Álvarez-Román MT; Fernández-Fuertes F; Sánchez-González B; Caparrós I; Jarque I; Mingot-Castellano ME; Hernández-Rivas JA; Martín-Salces M; Solán L; Beneit P; Jiménez R; Bernat S; Andrade MM; Cortés M; Cortti MJ; Pérez-Crespo S; Gómez-Núñez M; Olivera PE; Pérez-Rus G; Martínez-Robles V; Alonso R; Fernández-Rodríguez A; Arratibel MC; Perera M; Fernández-Miñano C; Fuertes-Palacio MA; Vázquez-Paganini JA; Gutierrez-Jomarrón I; Valcarce I; de Cabo E; Sainz A; Fisac R; Aguilar C; Paz Martínez-Badas M; Peñarrubia MJ; Calbacho M; de Cos C; González-Silva M; Coria E; Alonso A; Casaus A; Luaña A; Galán P; Fernández-Canal C; Garcia-Frade J; González-Porras JR
Am J Hematol; 2015 Mar; 90(3):E40-3. PubMed ID: 25400215
[TBL] [Abstract][Full Text] [Related]
6. [Concomitant use of romiplostim and chemotherapy for advanced rectal cancer associated with idiopathic thrombocytopenic purpura].
Yamada M; Shinzaki S; Nishida T; Yamada T; Fujinaga T; Yakushijin T; Tatsumi T; Iijima H; Hiramatsu N; Tsujii M; Takehara T
Nihon Shokakibyo Gakkai Zasshi; 2014 Mar; 111(3):521-8. PubMed ID: 24598096
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Platinum-Resistant Recurrent Ovarian Cancer with Idiopathic Thrombocytopenic Purpura].
Hirayama T; Kin S; Ohta M; Saburo T; Kimoto S
Gan To Kagaku Ryoho; 2021 Jun; 48(6):821-824. PubMed ID: 34139731
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic thrombocytopenic purpura complicated by intracranial hemorrhage in a 78-year-old male.
Kobayashi H; Sagawa K; Watanabe N; Morito T; Kazuta Y; Takase Y; Kasukawa R
Fukushima J Med Sci; 1995 Jun; 41(1):79-86. PubMed ID: 8606045
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Idiopathic Thrombocytopenic Purpura during Adjuvant Chemotherapy for Colon Cancer].
Takahara Y; Ozawa S; Ogasawara T; Shida T; Nomura S; Sato Y; Takahashi M
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2145-7. PubMed ID: 26805292
[TBL] [Abstract][Full Text] [Related]
10. [Neutrophil recovery by eltrombopag treatment in a patient with adult-onset autoimmune neutropenia and immune thrombocytopenia].
Tokunaga M; Yamada M; Kondo A; Mishima M; Yoshikawa S; Inoue S; Morita T; Tominaga N
Rinsho Ketsueki; 2018; 59(3):310-314. PubMed ID: 29618690
[TBL] [Abstract][Full Text] [Related]
11. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.
Bussel JB; Provan D; Shamsi T; Cheng G; Psaila B; Kovaleva L; Salama A; Jenkins JM; Roychowdhury D; Mayer B; Stone N; Arning M
Lancet; 2009 Feb; 373(9664):641-8. PubMed ID: 19231632
[TBL] [Abstract][Full Text] [Related]
12. [A case of recurrent rectal cancer with idiopathic thrombocytopenic purpura showing rapid progression, suggesting disseminated intravascular coagulopathy].
Ohira G; Miyauchi H; Tohma T; Kuboshima M; Yoneyama Y; Matsubara H
Gan To Kagaku Ryoho; 2012 Jan; 39(1):139-42. PubMed ID: 22241370
[TBL] [Abstract][Full Text] [Related]
13. A case of gray platelet syndrome masked by immune thrombocytopenia at presentation.
Mizuno N; Kanamori E; Saito H; Murakami N; Tojo N; Tohda S
Acta Haematol; 2014; 132(2):163-5. PubMed ID: 24577417
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness of perioperative administration of eltrombopag in a patient with idiopathic thrombocytopenic purpura undergoing cardiovascular surgery].
Shomura S; Katayama Y; Kusagawa H; Komada T
Kyobu Geka; 2014 Mar; 67(3):203-6. PubMed ID: 24743530
[TBL] [Abstract][Full Text] [Related]
15. Suspected Immune Thrombocytopenic Purpura Induced by Lenalidomide for the Treatment of Myelodysplastic Syndrome with Deletion of Chromosome 5q: A Case Report.
Furukawa H; Nomura J; Kobayashi M; Abe S; Takeda T; Oka Y; Shirota Y; Kodera T; Okitsu Y; Takahashi S; Murakami K; Kameoka J
Tohoku J Exp Med; 2023 Jan; 259(2):113-119. PubMed ID: 36450481
[TBL] [Abstract][Full Text] [Related]
16. Portal vein thrombosis during eltrombopag treatment for immune thrombocytopenic purpura in a patient with liver cirrhosis due to hepatitis C viral infection.
Kawano N; Hasuike S; Iwakiri H; Nakamura K; Ozono Y; Kusumoto H; Nagata K; Kikuchi I; Yoshida S; Kuriyama T; Yamashita K; Muranaka T; Kawaguchi T; Sata M; Okamura T; Ueda A; Shimoda K
J Clin Exp Hematop; 2013; 53(2):151-5. PubMed ID: 23995112
[TBL] [Abstract][Full Text] [Related]
17. Efficiency and safety of eltrombopag for multi-line failed Chinese patients with immune thrombocytopenia: cases with decreased megakaryocyte response well from single-center experience.
Liu Q; Shen Y; Li Y; Hu H; Liu W; Zhao Y; Dong H; Shen Y; Zhou Y; Ye B; Wu D
Immunol Res; 2022 Feb; 70(1):67-74. PubMed ID: 34669176
[TBL] [Abstract][Full Text] [Related]
18. Acquired amegakaryocytic thrombocytopenia after durvalumab administration.
Suyama T; Hagihara M; Kubota N; Osamura Y; Shinka Y; Miyao N
J Clin Exp Hematop; 2021 Mar; 61(1):53-57. PubMed ID: 33431742
[TBL] [Abstract][Full Text] [Related]
19. [Maintenance of efficacy and its predictors after discontinuation of eltrombopag in adults with primary immune thrombocytopenia].
Sun HP; You JH; Chen QS; Wang J; Li JM
Zhonghua Xue Ye Xue Za Zhi; 2023 Jan; 44(1):32-37. PubMed ID: 36987720
[No Abstract] [Full Text] [Related]
20. Graves' disease-induced immune thrombocytopenic purpura in an African female: a case report.
Agyapong KO; Folson AA; Fiador K; Kootin-Sanwu C; Tufuor M; Bampoh SA; Fiscian H; Wonkyi R
J Med Case Rep; 2023 Apr; 17(1):122. PubMed ID: 37016396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
